The CD56dim NK subpopulation specifically present in HCC patients was characterized as CD160-Siglec-7-CD49a+, some of which expressed Siglec-10, ILT2, or PD-1 (Figure 2B, blue circle). This evidence concerns the gene CD160 and hepatocellular carcinoma.